Gilead Sciences signed a contract with four Indian pharmaceutical companies to produce its medication ‘Remdesivir’ which has been found effective in treatment of some COVID-19 patients.
Billionaire investor and stock market bull Rakesh Jhunjhunwala shared his viewpoints on the Indian markets and economy during an interview with Ramesh Damani.
Indian government announced complete ban on international flights in March while countries across the world were announcing restrictions to contain the spread of COVID-19.
Financial services major HSBC has predicted 7.2 percent contraction for India’s GDP, as per comments from HSBC India’ Chief Economist Pranjul Bhandari.
